Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dendreon
Dendreon
Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill
Fierce Pharma
Tue, 12/7/21 - 11:41 pm
Dendreon
Provenge
pharma marketing
prostate cancer
celebrity endorsements
Dendreon makes leap to become cell therapy CMO
Biopharma Reporter
Fri, 06/25/21 - 11:04 am
Dendreon
cell therapy
CMOs
AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy
Endpoints
Thu, 06/18/20 - 10:55 am
AbbVie
Mitchell Gold
Dendreon
ALPN-101
immunology
Alpine Immune Sciences
lupus
Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site
Fierce Pharma
Thu, 05/23/19 - 09:59 am
Dendreon
prostate cancer
Provenge
drug manufacturing
ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge
Fierce Pharma
Tue, 06/6/17 - 09:55 am
ASCO 2017
Dendreon
prostate cancer
Provenge
vaccines
Dendreon eyes real-world data boost for lagging prostate cancer med Provenge
Fierce Pharma
Mon, 05/15/17 - 09:18 am
vaccines
Dendreon
prostate cancer
Provenge
Former Dendreon CEO debuts new public company in reverse merger
BioPharma Dive
Wed, 04/19/17 - 04:19 pm
Dendreon
reverse merger
Mitchell Gold
Alpine Immune Sciences
Nivalis
Valeant: Why The Dendreon Sale Changes Everything
Seeking Alpha
Tue, 01/17/17 - 09:57 am
Valeant Pharmaceuticals
Dendreon
JPM: Valeant sells off Dendreon, skincare brands for $2.1B
BioPharma Dive
Wed, 01/11/17 - 09:58 am
Valeant Pharmaceuticals
Dendreon
M&A
JPMHC 2017
Chinese Sanpower Group
In Juno patient deaths, echoes seen of earlier failed company
Stat
Sat, 07/9/16 - 09:16 am
Juno Therapeutics
clinical trials
CAR-T
Dendreon
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Forbes
Mon, 06/13/16 - 10:36 am
Mitchell Gold
Dendreon
cancer immunotherapy
Alpine Immune Sciences
Valeant welcomes Dendreon into the fold with a 77-job shearing
Fierce Pharma
Tue, 03/3/15 - 01:25 pm
Dendreon
Valeant Pharmaceuticals
layoffs
Can Valeant transform Dendreon's ailing Provenge into a viable cancer competitor?
Fierce Pharma Marketing
Wed, 02/11/15 - 12:04 pm
Valeant Pharmaceuticals
Dendreon
Provenge
prostate cancer
Valeant Pharmaceuticals Signs Stalking-Horse Deal With Dendreon Corporation (DNDN)
Bidness Etc.
Fri, 01/30/15 - 08:19 am
Valeant Pharmaceuticals
Dendreon
Provenge
M&A
Biotech investor explains why Juno Therapeutics won't be like Dendreon
Bizjournals.com
Fri, 01/2/15 - 07:31 pm
Juno Therapeutics
Dendreon
Dendreon heads to February bankruptcy auction without initial bidder
Bizjournals.com
Tue, 12/30/14 - 09:25 pm
Dendreon
bankruptcy
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs
TheStreet.com
Tue, 12/16/14 - 12:06 pm
biotech
Vertex Pharmaceuticals
Myriad Genetics
Dendreon
Celgene
Regeneron
Dendreon's Alternate Reality
Motley Fool
Thu, 12/4/14 - 10:40 am
Dendreon
BFG Pharma
M&A
Provenge
prostate cancer
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Barron's
Wed, 11/12/14 - 11:02 am
Dendreon
bankruptcy
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »